Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
2 hedge funds and large institutions have $8.92M invested in Motif Bio plc ADRs in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
1% more capital invested
Capital invested by funds: $8.81M → $8.92M (+$113K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $8.91M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $8K | -$7.59K | -891 | -48% |
|
MTFB Hedge Fund Activity: Q3 2018 in Review
2 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q3 2018, worth a combined $8.92M — up 1.3% from $8.81M a quarter earlier.
Fund positioning in MTFB was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $7.59K.
- 2 institutional investors held Motif Bio plc ADRs (MTFB) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $8.92M of Motif Bio plc ADRs stock for Q3 2018, up 1.3% quarter-over-quarter.
- 0 funds opened new Motif Bio plc ADRs positions in Q3 2018 and 0 closed out.
- The largest Motif Bio plc ADRs seller in Q3 2018 was UBS Group, an estimated $7.59K sold.
Based on aggregated 13F filings for Q3 2018.